Jane Street’s Coherus Oncology CHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$22K Sell
13,000
-12,900
-50% -$22.9K ﹤0.01% 11180
2025
Q4
$36.8K Sell
25,900
-1,500
-5% -$2.19K ﹤0.01% 10585
2025
Q3
$44.9K Buy
+27,400
New +$30.5K ﹤0.01% 10379
2025
Q1
Sell
-330,700
Closed -$456K 9542
2024
Q4
$456K Buy
+330,700
New +$371K ﹤0.01% 6965
2024
Q2
Sell
-19,100
Closed -$45.6K 9442
2024
Q1
$45.6K Sell
19,100
-419,900
-96% -$1.03M ﹤0.01% 8756
2023
Q4
$1.46M Buy
439,000
+383,700
+694% +$1.03M ﹤0.01% 4871
2023
Q3
$207K Buy
+55,300
New +$255K ﹤0.01% 7573
2023
Q2
Sell
-12,500
Closed -$85.5K 8749
2023
Q1
$85.5K Sell
12,500
-1,000
-7% -$7.76K ﹤0.01% 8294
2022
Q4
$107K Buy
+13,500
New +$104K ﹤0.01% 8053
2022
Q1
Sell
-17,200
Closed -$275K 10345
2021
Q4
$275K Buy
17,200
+4,500
+35% +$78.7K ﹤0.01% 8337
2021
Q3
$204K Sell
12,700
-9,200
-42% -$135K ﹤0.01% 8805
2021
Q2
$303K Buy
+21,900
New +$310K ﹤0.01% 8129
2020
Q3
Sell
-12,300
Closed -$220K 7189
2020
Q2
$220K Buy
+12,300
New +$208K ﹤0.01% 6248

Other funds holding CHRS